|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 47/14 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 47/44 | (2013.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 25/04 | (2018.01) |
| (11) | Number of the document | 3302477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16799432.6 |
| Date of filing the European patent application | 2016-05-27 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/000857 |
| Date | 2016-05-27 |
| (87) | Number | WO 2016/189393 |
| Date | 2016-12-01 |
| (30) | Number | Date | Country code |
| 201514723996 | 2015-05-28 | US | |
| 201562255805 P | 2015-11-16 | US |
| (72) |
LI, Chan-Jung , TW
CHOU, David, Chih-Kuang , US
HUANG, Jin-Ding , TW
TSAI, Shin, Jr. , TW
KUO, Shu-Wen , TW
TIEN, Yu-En , TW
|
| (73) |
Lumosa Therapeutics Co., Ltd. ,
4F
No. 3-2 Park Street
Nangang District, Taipei 11503,
TW
Shanghai Lumosa Therapeutics Co., Ltd. , Room 3026, 3rd Floor, Building 1 No. 146, 1st East Fute Road Shanghai Pilot Free Trade Zone, Shanghai 200131, CN |
| (54) | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER |
| PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER |